You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

CLINICAL TRIALS PROFILE FOR MIRCERA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MIRCERA

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00048035 ↗	A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia	Completed	Hoffmann-La Roche	Phase 2	2002-03-01	This study will determine the appropriate dose and frequency of administration of iv Mircera maintenance therapy in hemodialysis patients with chronic renal anemia who were previously receiving iv epoetin. The anticipated time on study treatment is 3-12 months and the target sample size is <100 individuals.
NCT00048048 ↗	A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.	Completed	Hoffmann-La Roche	Phase 2	2002-03-01	This study will evaluate the efficacy and safety of different subcutaneous starting doses and dosing frequencies of Mircera in anemic patients with chronic kidney disease not yet on dialysis. The anticipated time on study treatment is 3-12 months and the target sample size is <100 individuals.
NCT00077597 ↗	A Study of Mircera for the Treatment of Anemia in Dialysis Patients	Completed	Hoffmann-La Roche	Phase 3	2004-02-01	This study will assess the efficacy and safety of Mircera given intravenously in the treatment of renal anemia in chronic kidney disease patients on dialysis who are not currently receiving epoetin or any other erythropoietic substance. The anticipated time on study treatment is 1-2 years and the target sample size is 100-500 individuals.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MIRCERA

Condition Name

Chart
Table

Condition Name for MIRCERA
Intervention	Trials
Anemia	57
Kidney Disease, Chronic	3
Chronic Renal Anemia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MIRCERA
Intervention	Trials
Anemia	56
Renal Insufficiency, Chronic	25
Kidney Diseases	25
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MIRCERA

Trials by Country

Map
Table

Trials by Country for MIRCERA
Location	Trials
United States	263
Canada	39
Spain	31
Italy	28
Germany	21
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MIRCERA
Location	Trials
California	16
Michigan	14
New York	12
Texas	12
Ohio	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MIRCERA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MIRCERA
Clinical Trial Phase	Trials
Phase 4	14
Phase 3	41
Phase 2	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MIRCERA
Clinical Trial Phase	Trials
Completed	62
Terminated	7
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MIRCERA

Sponsor Name

Chart
Table

Sponsor Name for MIRCERA
Sponsor	Trials
Hoffmann-La Roche	66
FibroGen	1
Novotech (Australia) Pty Limited	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MIRCERA
Sponsor	Trials
Industry	74
Other	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.